Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Neuromodulation Stories

2012-04-26 10:25:37

MINNEAPOLIS, April 26, 2012 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that Novitas Solutions (formerly Highmark Medicare Services) on April 23, 2012 informed the Centers for Medicare and Medicaid Services that it has retired the non-coverage provisions concerning Posterior Tibial Nerve Stimulation (PTNS) from their Local...

2012-03-21 02:24:15

LOS ANGELES, March 21, 2012 /PRNewswire/ -- NeuroSigma, Inc., a Los Angeles-based medical device company, is pleased to recognize the accomplishments of Antonio A.F. De Salles, M.D., Ph.D., Professor of Neurosurgery and Head of the Stereotactic Surgery Division of the Department of Neurosurgery at UCLA, as one of the 2012 recipients of the Pioneer in Medicine Award from the Society of Brain Mapping and Therapeutics (SBMT). The Society is honoring Dr. De Salles with the award in...

2012-03-16 08:00:00

MINNEAPOLIS and GENEVA, March 16, 2012 /PRNewswire/ -- Milestone comes 25 years after the first DBS implant for Tremor carried out in Grenoble, France Medtronic, Inc. (NYSE: MDT) today announced that a patient from Kempenhaeghe-Heeze (The Netherlands) is the first patient to be enrolled into the MORE (MedtrOnic Registry for Epilepsy) Registry which is designed to look at the long-term efficacy, quality of life impact and safety of deep brain stimulation (DBS) in patients...

2012-03-06 12:45:00

Stryker´s Acquisition of Boston Scientific´s Neurovascular Division Propels Company to Lead Neuroradiology Markets According to an iData Research Report Vancouver, BC (PRWEB) March 06, 2012 According to a new report by iData Research (http://www.idataresearch.net), the leading global authority in medical device market research, the U.S. neurological device market, was valued at over $2.7 billion in 2011. By 2018, the market is expected to reach over $5.3 billion, fueled by the...

2011-12-08 07:30:00

NATICK, Mass. and LAS VEGAS, Dec. 8, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces U.S. Food and Drug Administration (FDA) approval of the Infinion(TM) 16 Percutaneous Lead for its Precision Plus(TM) Spinal Cord Stimulator (SCS) System, the first rechargeable SCS device for chronic pain management. The Infinion 16 Lead is the world's first and only 16-contact percutaneous lead and the latest innovation in Boston Scientific's comprehensive percutaneous lead...

2011-11-09 06:00:00

MINNEAPOLIS, Nov., 9, 2011 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced the issuance of United States Patent No. 8,046,082 covering the stimulator used in the Urgent® PC Neuromodulation System. The Urgent PC Neuromodulation System is an office-based, non-surgical system, used to treat overactive bladder syndrome (OAB) and the...

2011-10-14 06:11:00

CAMPBELL, Calif., Oct. 14, 2011 /PRNewswire/ -- EMKinetics, Inc. announced today initiation of the TranStim(TM) Transdermal Neuromodulation System pivotal trial for patients suffering from urge incontinence and overactive bladder. The 120-person trial will be conducted at 10-15 US centers. Submission for CE mark and 510(k) clearance will follow the completion of the study. EMKinetics' TranStim therapy builds on the body of evidence that posterior tibial nerve stimulation (PTNS) can...

2011-10-04 08:01:00

VALENCIA, Calif., Oct. 4, 2011 /PRNewswire/ -- Bioness Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark Approval by the European Union for its NESS H200® Wireless Hand Rehabilitation System. This new wireless system allows patients to better integrate the NESS H200 into daily life, increasing therapy time which may lead to increased patient compliance and better outcomes. The NESS H200 Wireless is...

2011-09-07 08:00:00

HOUSTON, Sept. 7, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in epilepsy management, today announced it will participate in the 2011 UBS Global Life Sciences Conference on Wednesday, September 21, 2011, in New York. Dan Moore, Cyberonics' President and Chief Executive Officer, will speak to the attendees of the conference 10:00 AM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics...

2011-08-25 15:00:00

HOUSTON, Aug. 25, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX), a global leader in epilepsy management, today announced that it will participate in the 2011 Baird Healthcare Conference on Thursday, September 8, 2011, in New York. Dan Moore, Cyberonics' President and Chief Executive Officer, will speak to the attendees of the conference at 2:15 PM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics...